Clinical Trials List
2018-01-01 - 2030-12-31
Phase III
Recruiting6
ICD-10K51.90
Ulcerative colitis, unspecified, without complications
ICD-10K51.911
Ulcerative colitis, unspecified with rectal bleeding
ICD-10K51.912
Ulcerative colitis, unspecified with intestinal obstruction
ICD-10K51.913
Ulcerative colitis, unspecified with fistula
ICD-10K51.914
Ulcerative colitis, unspecified with abscess
ICD-10K51.918
Ulcerative colitis, unspecified with other complication
ICD-10K51.919
Ulcerative colitis, unspecified with unspecified complications
ICD-9556.9
Ulcerative colitis, unspecified
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳家昌 Digestive System Department
- 趙德馨 Digestive System Department
- FAN -FENG CHIANG Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王彥博 Digestive System Department
- 盧俊良 Digestive System Department
- Jiing-Chyuan Luo Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳介章 Digestive System Department
- Huey-Ling Chen Division of Pediatrics
- 吳嘉峰 Division of Pediatrics
- 曾屏輝 Digestive System Department
- HAN-MO CHIU Digestive System Department
- YEN-HSUAN NI Division of Pediatrics
- 陳彥年 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李伯賢 Digestive System Department
- 陳繹中 Division of Colorectal Surgery
- Cheng-Tang Chiu Digestive System Department
- Wen-Sy Tsai Division of Colorectal Surgery
- 許振銘 Digestive System Department
- Ming-Wei Lai Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張安迪 Digestive System Department
- Chun-Lung Feng Digestive System Department
- Tsung-Yu Tsai Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
942 participants
